Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a ...
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts ...
Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.
Medical device maker Dexcom beat fourth-quarter sales estimates helped by resilient demand for its continuous glucose monitors (CGMs) used by patients with diabetes.
Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...
A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...
Retirement Systems of Alabama lowered its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.5% in the 4th quarter, ...
Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket ...
Dexcom (Nadsaq:DXCM) shares fell after hours today on fourth-quarter results that came in mixed compared to the consensus forecast.
system. Eversense 365 is well-suited to address common limitations of AID systems and the companies are advancing partnership discussions with various pump manufacturers. The Eversense Continuous ...